Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Patent
1997-06-19
1999-12-28
Powers, Fiona T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
5142242, 514456, A61K 31655, A61K 3147, A61K 31495, A61K 3135
Patent
active
060082089
ABSTRACT:
Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or "linker" defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 .ANG., are effective in treating conditions associated with bone deficits. The compounds can be administered to vertebrate subjects alone or in combination with additional agents that promote bone growth or that inhibit bone resorption. They can be screened for activity prior to administration by assessing their ability to effect the transcription of a reporter gene coupled to a promoter associated with a bone morphogenetic protein and/or their ability to stimulate calvarial growth in model animal systems.
REFERENCES:
patent: 4761471 (1988-08-01), Urist
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5703118 (1997-12-01), Durand et al.
patent: 5741784 (1998-04-01), Sohda et al.
patent: 5804590 (1998-09-01), Fujiwara et al.
McDonald et al., Chemical Abstracts, 71:22118 (1969).
Del Corona et al., Chemical Abstracts, 117:191784 (1992).
Del Corona et al., Eur. J. Med. Chem. 1992, 27(4), 419-423.
Bangham, A.D. et al., "Diffusion of Univalent Ions Across the Lamellae of Swollen Phospholipids," J. Mol Biol (1965) 23:238-252.
Beck, et al., "Rapid Publication TGF-.beta..sub.1 Induces Bone Closure of Skull Defects," J Bone Min Res (1991) 6(11):1257-1265.
Bonewald, et al., J Biol Chem (1992) 267:8943-8949.
Caplan, A., "Mesenchymal Stem Cells" J Orthop Res (1991) 9:641-650.
Casez, et al., "Dual-Energy X-Ray Absorptiometry for Measuring Total Bone Mineral Content in the Rat:Study of Accuracy and Precision," Bone and Mineral (1994) 26:61-68.
Edelman, et al., "Controlled and Modulated Release of Basic Fibroblast Growth Factor," Biomaterials (1991) 12:619-626.
Ferretti, J., "Perspectives of pQct Technology Associated To Biomechanical Studies in Skeletal Research Employing Rat Models," Bone (1995) 17:353S-364S.
Ghosh-Choudhery, N., et al., "Immortalized Murine Osteoblasts Derived from BMP 2-T Antigen Expressing Transgenic Mice," Endocrinology (1996) 137:331-339.
Gowan M. & Mundy G., "Actions of Recombinant Interleukin 1, Interleukin 2, and Interferon-.gamma. on Bone Resorption in Vitro," J. Immunol (1986) 136:2478-2482.
Harris, S.E., et al., "Effects of Transforming Growth Factor .beta. on Bone Nodule Formation and Expression of Bone Morphogenetic Protein 2, Osteocalcin, Osteopontin, Alkaline Phosphatase, and Type 1 Collagen mRNA in Long-Term Cultures of Fetal Rat Calvarial Osteoblast," Journal of Bone and Mineral Research (1994) 9(6):855-863.
Irving, H.M.N.H., et al., Anal Chim Acta (1970)49:261-266.
Kim, S., et al., "Preparation of Multivesicular Liposomes," Biochim Biophys Acta (1983) 728:339-348.
Kimmel, et al., "The Effect of Recombinant Human (1-84) or Synthetic Human (1-34) Parathyroid Hormone on the Sleeton of Adult Osteopenic Ovariectomized Rats," Endocrinology (1993) 132:1577-1584.
Ksander, et al., "Exogenous Transforming Growth Factor-Beta 2 Enhances Connective Tissue Formation and Wound Strength in Guinea Pig Dermal Wounds Healing by Secondary Intent," Ann Surg (1990) 211(3):288-294.
Laval-Jeanetet, A., et al., "Dual-EnergyX-Ray Absorptiometry of the Calcaneus: Comparison with Vertebral Dual-Energy X-Ray Absorptiometry and Quantitative Computed Tomography," Calcif Tissue Intl (1995) 56:14-18.
Leserman, L., et al., "Targeting to Cells of Fluorescent Liposomes Covalently Coupled With Monoclonal Antibody or Protein A," Nature (1980) 288:602-604.
Mayer, et al., "Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure," Biochim Biophys Acta (1986) 858:161-168.
Mayhew, E., et al., (1984) 775:169175.
McDonald, W.S., et al., Chem Comm (1969) 392-393.
Mundy, G.R., "Regulation of Bone Formation by Bone Morphogenetic Proteins and Other Growth Factors," Clinical Orthopaedics and Related Research (1996) 323:24-28.
Olson, F., et al., "Preparation of Liposomes of Defined Size Deistribution by Extrusion Through Polycarbonate Membranes," Biochim Biophys Acta (1979) 557:9-23.
Sampath, et al., "Isolation of Osteogenin, an Extracellular Matrix-Associated, Bone-Inductive Protein, by Heparin Affinity Chromatography," Proc Natl Acad Sci USA (1987) 84:7109-7113.
Stein, G.S., et al., "Bone cell Differentiation: a functionally coupled relationship between expression of cell-growth-and tissure-specific genes," Current Opinion in Cell Biology (1990) 2:1018-1027.
Szoka, F., et al., "Procedure for Preparation of Liposomes With Large Internal Aqueous Space and High Capture by Reverse-Phase Evaporation," Proc Natl Acad Sci USA (1978) 75:4194-4198.
Tencer, et al., "The Effect of Local Controlled Release of Sodium Fluoride on the Stimulation of Bone Growth," J. Biomed Mat Res (1989) 23:571-589.
Urist, M.R., "Bone: Formation by Autoinduction," Science (1965) 150:893-899.
Wozney, J.M., et al., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science (1988) 242:1528-1534.
Wozney, J.M., "The Bon Morphogenetic Protein Family and Osteogenesis," Molecular Reproductive and Development (1992) 32:160-167.
U.S. Application No. 08/458,434, Jun. 2, 1995.
Baindur Nand
Harris Scott M.
Kontoyianni Maria
Mundy Gregory R.
Orme Mark W.
Osteoscreen Inc.
Powers Fiona T.
ZymoGenetics Corporation
LandOfFree
Compositions and methods for treating bone deficit conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating bone deficit conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating bone deficit conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382519